Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclosporine A in Reperfused Acute Myocardial Infarction
NCT00403728Phase 3Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2004
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cyclosporine in acute myocardial infarction (AMI) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Infarct size evaluated by AUC of CK and Troponin I release at 72 hours. Status: unknown.
02
Drugs
cyclosporine
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00403728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403728.